Baudax Bio Announces FDA Approval of ANJESO™ for the Management of Moderate to Severe Pain

Ads

You May Also Like

Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference

PARSIPPANY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

Genocea to Present at Two March Investor Conferences

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...